LIGAND PHARMACEUTICALS INC Quarterly Other Assets, Current in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Ligand Pharmaceuticals Inc quarterly Other Assets, Current history and growth rate from Q4 2010 to Q3 2024.
  • Ligand Pharmaceuticals Inc Other Assets, Current for the quarter ending September 30, 2024 was $19.7M, a 841% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $19.7M +$17.6M +841% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $7.12M +$4.35M +157% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $7.31M +$4.98M +214% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $3.84M +$1.57M +69.3% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 $2.1M -$8.65M -80.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.77M -$5.03M -64.5% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $2.33M -$2.33M -49.9% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.27M -$1.3M -36.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $10.7M +$5.59M +108% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $7.8M +$1.53M +24.5% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $4.66M -$1.05M -18.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.57M -$251K -6.57% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $5.16M +$1.97M +61.7% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $6.27M +$781K +14.2% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $5.71M +$768K +15.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.82M -$912K -19.3% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $3.19M -$1.85M -36.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $5.49M -$183K -3.23% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $4.94M -$4.29M -46.5% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $4.73M -$6.29M -57% Dec 31, 2019 10-K 2021-02-24
Q3 2019 $5.04M -$20.3M -80.1% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $5.67M -$7.15M -55.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $9.23M +$3.58M +63.4% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $11M +$9.51M +628% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $25.3M +$24.2M +2179% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $12.8M +$11.7M +1096% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $5.65M +$5.01M +781% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $1.51M -$661K -30.4% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $1.11M -$1.64M -59.7% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $1.07M -$1.53M -58.8% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $641K -$921K -59% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $2.18M +$267K +14% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $2.76M +$979K +55.1% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 $2.6M +$801K +44.5% Jun 30, 2016 10-Q/A 2016-11-15
Q1 2016 $1.56M +$636K +68.7% Mar 31, 2016 10-Q/A 2016-11-15
Q4 2015 $1.91M +$66K +3.58% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $1.78M +$175K +10.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $1.8M +$678K +60.4% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $926K +$85K +10.1% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $1.84M +$883K +92.1% Dec 31, 2014 10-K/A 2016-11-15
Q3 2014 $1.6M +$90K +5.95% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $1.12M -$88K -7.27% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $841K -$145K -14.7% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $959K +$130K +15.7% Dec 31, 2013 10-K 2015-02-23
Q3 2013 $1.51M +$497K +49% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $1.21M -$814K -40.2% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $986K -$1.79M -64.5% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $829K -$515K -38.3% Dec 31, 2012 10-K/A 2014-12-12
Q3 2012 $1.02M -$648K -39% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $2.03M +$157K +8.41% Jun 30, 2012 10-Q/A 2012-11-14
Q1 2012 $2.78M Mar 31, 2012 10-Q/A 2012-11-14
Q4 2011 $1.34M +$624K +86.7% Dec 31, 2011 10-K 2013-03-14
Q3 2011 $1.66M Sep 30, 2011 10-Q/A 2012-02-10
Q2 2011 $1.87M Jun 30, 2011 10-Q/A 2012-02-10
Q4 2010 $720K Dec 31, 2010 10-K/A 2012-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.